Oncogene news from around the world
A new RNA editing tool could enhance cancer treatment
Cell therapies for cancer can be potentially enhanced using a CRISPR RNA-editing platform, according to…
Browsing: Genetics
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
This review is designed by Professor Changyang Gong and written by his PhD student Shiyao…
Genetic alterations in thyroid cancer mediate resistance to BRAF inhibition and anaplastic transformation
A new research perspective was published in Oncotarget’s Volume 15 on January 24, 2024, entitled, “Genetic alterations in…
Molecular profiles of tissue plus circulating tumour DNA can better guide cancer care
The current standard of care for identifying targetable mutations in cancer treatment is to conduct…
103 genes that cause inherited diseases when mutated can also increase cancer risk
About one hundred so-called cancer predisposition genes (CPGs) are known. The probability of developing cancer…
Special RNA suppresses the formation of breast cancer cells
Breast cancer is the most common cancer in women. The development of breast cancer often…
Updated genomic landscape for paediatric acute myeloid leukaemia enables new treatment possibilities
Compared to adult cancers, paediatric cancers often have distinctive genetic causes. This means there is…
Analysing how cancer mutations interact may improve targeted therapies
Cancer arises when multiple mutations result in relentless, inappropriate cell growth. But these mutations don’t…
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Epigenetic regulation is a dynamic and reversible process characterised by the addition and removal of…
Criteria for better assessment of rare genetic variants that can lead to hereditary colorectal cancer
Genetic confirmation of the suspected diagnosis of “hereditary colorectal cancer” is of great importance for…